Holen Sie sich die Stockscreener-App
1.89
0.53%
-0.01
Schlusskurs vom Vortag:
$1.90
Offen:
$1.96
24-Stunden-Volumen:
35,182
Relative Volume:
0.08
Marktkapitalisierung:
$9.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.3946
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
-2.58%
1M Leistung:
+3.85%
6M Leistung:
+263.46%
1J Leistung:
-46.61%
1-Tages-Spanne:
$1.8519
$1.99
1-Wochen-Bereich:
$1.83
$2.02
52-Wochen-Spanne:
$0.4748
$4.25
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.89 | 10.55M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Why institutional investors increase stakes in Matinas Biopharma Holdings Inc. stock2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Will Matinas BioPharma Holdings Inc. stock return to pre crisis levelsPrice Action & Precise Trade Entry Recommendations - newser.com
Will Matinas BioPharma Holdings Inc. stock outperform international peersJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com
How high can Matinas BioPharma Holdings Inc. stock goPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Is Matinas Biopharma Holdings Inc. stock undervalued historicallyWeekly Trend Recap & Community Verified Swing Trade Signals - newser.com
Will Matinas Biopharma Holdings Inc. stock keep high P E multiplesJuly 2025 Update & Consistent Return Strategy Ideas - newser.com
Why Matinas BioPharma Holdings Inc. stock is in analyst buy zone2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 20252025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com
Why millennials buy Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com
Why Matinas BioPharma Holdings Inc. (6LJ0) stock gets analyst attentionDip Buying & Technical Confirmation Trade Alerts - newser.com
What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Ranking Matinas BioPharma Holdings Inc. among high performing stocks via toolsJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
How to build a custom watchlist for Matinas BioPharma Holdings Inc.Trend Reversal & Capital Protection Trade Alerts - newser.com
Can trapped investors hope for a rebound in Matinas BioPharma Holdings Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Understanding Matinas BioPharma Holdings Inc.’s price movementEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
What to expect from Matinas BioPharma Holdings Inc. in the next 30 daysJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Why retail traders accumulate Matinas BioPharma Holdings Inc. (6LJ0) stockEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
How Matinas Biopharma Holdings Inc. stock moves in volatile trading sessions2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Can Matinas BioPharma Holdings Inc. stock attract ESG capital inflowsJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Is Matinas BioPharma Holdings Inc. stock a dividend growth opportunity - newser.com
Will Matinas Biopharma Holdings Inc. stock outperform energy sector in 2025Weekly Investment Recap & Entry Point Confirmation Alerts - newser.com
What drives Matinas BioPharma Holdings Inc stock priceTrendline Breakouts & High Return Stock Ideas - earlytimes.in
Matinas BioPharma Holdings Inc 6LJ0 Stock Analysis and ForecastTrading Volume Surges & Double Or Triple Profits - earlytimes.in
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):